IE42793L - Treatment of colitis - Google Patents

Treatment of colitis

Info

Publication number
IE42793L
IE42793L IE760749A IE74976A IE42793L IE 42793 L IE42793 L IE 42793L IE 760749 A IE760749 A IE 760749A IE 74976 A IE74976 A IE 74976A IE 42793 L IE42793 L IE 42793L
Authority
IE
Ireland
Prior art keywords
colitis
treatment
Prior art date
Application number
IE760749A
Other versions
IE42793B1 (en
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of IE42793L publication Critical patent/IE42793L/en
Publication of IE42793B1 publication Critical patent/IE42793B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
IE749/76A 1975-04-09 1976-04-09 Preparation for treatment of colitis IE42793B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7504049A SE7504049L (en) 1975-04-09 1975-04-09 COLON PREPARATION

Publications (2)

Publication Number Publication Date
IE42793L true IE42793L (en) 1976-10-09
IE42793B1 IE42793B1 (en) 1980-10-22

Family

ID=20324216

Family Applications (1)

Application Number Title Priority Date Filing Date
IE749/76A IE42793B1 (en) 1975-04-09 1976-04-09 Preparation for treatment of colitis

Country Status (12)

Country Link
BE (1) BE840552A (en)
DE (1) DE2614296A1 (en)
DK (1) DK153376A (en)
FI (1) FI56772C (en)
FR (1) FR2306710A1 (en)
GB (1) GB1538123A (en)
IE (1) IE42793B1 (en)
LU (1) LU74732A1 (en)
NL (1) NL7603600A (en)
NO (1) NO761101L (en)
NZ (1) NZ180552A (en)
SE (1) SE7504049L (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52139715A (en) * 1976-05-14 1977-11-21 Nippon Kayaku Co Ltd Coated granules of alkali polyacrylate
FR2471186A1 (en) * 1979-12-10 1981-06-19 Roussel Uclaf NEW COLIC DELITESCENCE TABLETS AND THEIR PREPARATION PROCESS
US4444761A (en) * 1981-05-04 1984-04-24 Syntex (U.S.A.) Inc. Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4521401A (en) * 1983-01-03 1985-06-04 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of quinidine
EP0273209B1 (en) * 1986-12-30 1992-01-15 American Cyanamid Company Composition of matter containing polycarbophil
GB8817015D0 (en) * 1988-07-16 1988-08-17 Reckitt & Colmann Prod Ltd Method of treatment
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
DE527942T1 (en) * 1990-05-04 1994-03-03 Perio Prod Ltd DISPENSING SYSTEM IN COLON.
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Colonic drug delivery system
DE9212938U1 (en) * 1992-09-25 1992-11-26 Boehringer Ingelheim Gmbh, 6507 Ingelheim Calcium polycarbophil preparation for taking high doses of active ingredients
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
KR20200003827A (en) 2017-04-14 2020-01-10 젤레시스 엘엘씨 Compositions and Methods for Treating or Preventing Intestinal Permeability-Related Disorders

Also Published As

Publication number Publication date
DE2614296A1 (en) 1976-10-21
NL7603600A (en) 1976-10-12
FR2306710B1 (en) 1979-07-13
NZ180552A (en) 1978-07-28
FR2306710A1 (en) 1976-11-05
GB1538123A (en) 1979-01-10
FI760948A (en) 1976-10-10
DK153376A (en) 1976-10-10
FI56772B (en) 1979-12-31
IE42793B1 (en) 1980-10-22
FI56772C (en) 1980-04-10
BE840552A (en) 1976-10-11
LU74732A1 (en) 1977-02-04
SE7504049L (en) 1976-10-10
NO761101L (en) 1976-10-12

Similar Documents

Publication Publication Date Title
ZA765406B (en) Treatment of small articles
GB1550835A (en) Treatment of tobacco
AU2076476A (en) Aracterizat-ion of bodies
GB1543157A (en) Treatment of fibres
IL51153A0 (en) Treatment of waste
ZA764855B (en) Treatment of pigment
GB1540441A (en) Treatment of blood plasma
ZA764072B (en) Treatment of solid-liquid-gas mixtures
ZA764653B (en) Treatment of endotoxaemia
ZA763339B (en) Treatment of pigment
IE42793L (en) Treatment of colitis
GB1554283A (en) Treatment of glass
JPS5210834A (en) Surface treatment of metal
ZA762669B (en) Treatment of neoplasias
JPS5212976A (en) Treatment of unicellular preotein
ZA763340B (en) Treatment of pigment
JPS51139618A (en) Treatment of animal
ZA765733B (en) Treatment of effluent
JPS5218810A (en) Complex medical composition of estrogennprostaglangin
ZA762513B (en) Treatment of tire making components
JPS5242997A (en) Treatment of wool
GB1547293A (en) Treatment of materials with organo-halosilanes
PH12349A (en) Treatment of seedlings
ZA765293B (en) Treatment of electrodes
JPS51120940A (en) Surface treatment of metals